Deutsche Bank defends UnitedHealth (UNH)

Deutsche Bank defends UnitedHealth Group (NYSE: UNH) following 7% decline this week due to concerns on commercial MLR outlook in 1Q07 report.The firm reaffirms their Buy rating on UNH and said they should meet or modestly exceed their Q1 EPS forecast of $0.71.